GOAL
This educational activity will provide neurologists and multiple sclerosis (MS) nurses with up-to-date information about neurodegeneration, current therapies, the use of neuroimaging in the clinical setting, and methods for managing patients with MS and improving their adherence.
Return to Top
OVERVIEW
Multiple sclerosis has traditionally been classified as a demyelinating disease, but in recent years, the importance of neurodegeneration and gray-matter involvement has become increasingly apparent, and strategies targeted at neuroprotection have provided novel therapeutic areas. The presentation and course of MS is highly variable and often unpredictable. The diagnostic criteria continue to evolve, reflecting ongoing advancement in neuroimaging and neuroimmunology.
However, many questions remain:
When should we start therapy? Which therapies should be used? When should we switch therapies? What diagnostic tests should be performed? How can we optimize adherence? This symposium will bring together leaders in the field of MS to explore the latest diagnostic and therapeutic advances for improving patient outcomes.
Return to Top
INTENDED AUDIENCE
This activity is designed for neurologists and MS nurses. No prerequisites required.
Return to Top
HOW TO RECEIVE CREDIT OR CONTACT HOURS
After viewing this archived webcast, participants may receive credit or contact hours by completing the CME/CNE test, evaluation, and receiving a score of 70% or higher. A certificate of participation will be available online immediately following successful completion of the activity.
FACULTY
Full Disclosure Policy Affecting CME Activities
As a provider accredited by the Accreditation Council for Continuing Medical Education, it is the policy of the Johns Hopkins University School of Medicine to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation.
Policy on Faculty and Provider Disclosure
It is the policy of the Institute for Johns Hopkins Nursing to require our continuing nursing education faculty and planning committee members to disclose any financial relationships with companies providing program funding or manufacturers of any commercial products discussed in the educational activity.
The Course Directors and Participating Faculty reported the following:
Course Directors
John Ratchford, MD
The Johns Hopkins Multiple Sclerosis Center
Instructor
Department of Neurology
Johns Hopkins University School of Medicine
Dr Ratchford reports serving as a principal investigator on clinical trials and receiving salary support for his role from Novartis Pharmaceuticals Corporation; serving as a consultant for Sun Pharmaceuticals; and holding stock in Merck & Co, Inc.
Faith H. Howarth, MSN, EdM, CRNP, CS
Clinical Faculty
Johns Hopkins University School of Nursing
Ms Howarth reports having no relationships with commercial interests related to this activity.
Participating Faculty
Kathleen Costello, MS, ANP-BC, MSCN
The Johns Hopkins Multiple Sclerosis Center
Faculty Associate
Department of Neurology
Johns Hopkins University School of Medicine
Ms Costello reports prior to December 31, 2009 serving as a consultant for Biogen Idec, EMD Serono, Inc, Novartis Pharmaceuticals Corporation, and Teva Neuroscience; and receiving honoraria from and serving on the speakers’ bureau for Biogen Idec, EMD Serono, Inc, and Teva Neuroscience.
Michael K. Racke, MD
Professor and Chairman of Neurology
The Helen C. Kurtz Chair in Neurology
Department of Neurology
The Ohio State University College of Medicine
Dr Racke reports receiving grants/research support from the National Institutes of Health and the National Multiple Sclerosis Society; and serving as a consultant for Accelerated Cure Project, Diogenix, Eli Lilly, and Peptimmune Inc.
Nancy L. Sicotte, MD, FAAN
Associate Professor in Residence
Department of Neurology
Division of Brain Mapping
David Geffen School of Medicine at UCLA
Dr Sicotte reports having no relationships with commercial interests related to this activity.
Note: Grants to investigators at The Johns Hopkins University are negotiated and administered by the institution which receives the grant, typically through the Office of Research Administration. Individual investigators who participate in the sponsored project(s) are not directly compensated by the sponsor, but may receive salary or other support from the institution to support their effort on the project(s).
Off-Label Product Discussion
The audience is advised that presentations in this CME/CNE activity contain reference(s) to unlabeled or unapproved uses of drugs or devices:
Dr Ratchford— alemtuzumab, azathioprine, cladribine, corticosteroids, daclizumab, methotrexate, and rituximab.
All other faculty have indicated that they have not referenced unlabeled/unapproved uses of drugs or devices.
Non-Endorsement of Products
The Institute for Johns Hopkins Nursing does not endorse the use of any commercial products discussed or displayed in conjunction with this educational activity.
Return to Top
LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:
- DIFFERENTIATE the neuroprotective capabilities of current and future MS therapies.
- SELECT the optimal therapies for patients with MS during clinical case scenarios.
- EVALUATE how imaging and diagnostics relate to the clinical and immunological
effects of disease-modifying therapies and the scientific understanding of MS pathology
- APPLY appropriate use of neuroimaging/neurodiagnostic techniques to correlate the
clinical and immunologic effects of MS therapies during clinical case scenarios.
- IDENTIFY 2 interventions to improve adherence and compliance with disease-modifying
therapies in patients with MS.
- EVALUATE the effectiveness of current methods used in clinical practice to assess and
treat the invisible signs of MS and develop interventions to increase the quality of these
methods.
The Johns Hopkins University School of Medicine and The Institute for Johns Hopkins
Nursing take responsibility for the content, quality, and scientific integrity of this CME/CNE
activity.
Return to Top
CME/CNE INFORMATION
Accreditation Statement — This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Johns Hopkins University School of Medicine, the Institute for Johns Hopkins Nursing, The Consortium of Multiple Sclerosis Centers, and The International Organization of MS Nurses. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Institute for Johns Hopkins Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Credit Designation Statement — The Johns Hopkins University School of
Medicine designates this educational activity for a maximum of 4.0 AMA
PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate
with the extent of their participation in the activity.
This 4.0 contact hour educational activity is provided by the Institute for Johns Hopkins Nursing. Claim only those contact hours actually spent in the activity. Contact hours will be awarded for this educational activity until April 15, 2012.
The estimated time to complete this educational activity: 2 hours.
Release date: April 15, 2010. Expiration date: April 15, 2012.
Fee Information — There is no fee for this educational activity.
DISCLAIMER
The opinions and recommendations expressed by faculty and other experts whose input is included in this activity are their own. This activity is produced for educational purposes only. Use of the Johns Hopkins University School of Medicine and the Institute for Johns Hopkins Nursing names implies review of educational format, design, and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings, and adverse effects before administering pharmacologic therapy to patients.
INTERNET CME POLICY
The Office of Continuing Medical Education (CME) at the Johns Hopkins University School of Medicine is committed to protect the privacy of its members and customers. The Johns Hopkins University School of Medicine CME maintains its Internet site as an information resource and service for physicians, other health professionals, and the public. Continuing Medical Education at the Johns Hopkins University School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet-based activity. Your information will never be given to anyone outside of The Johns Hopkins University School of Medicine’s CME activity. CME collects only the information necessary to provide you with the services that you request.
THE INSTITUTE FOR JOHNS HOPKINS NURSING MISSION STATEMENT
The mission of the Institute for Johns Hopkins Nursing is to share the innovations of Johns Hopkins Nursing in practice, education, and research—locally, nationally, and globally.
Our goal in continuing nursing education is to bring you activities that reflect the expertise and creativity of Johns Hopkins Nursing. Our service values are quality, integrity, flexibility, and personal attentiveness. We appreciate your thoughts and welcome your concerns—please feel free to e-mail us: IJHN@son.jhmi.edu.
AGENDA
Please complete the pre-test, listen to the following presentations, and complete the post-test and evaluation to receive CME/CNE credit for this activity.
Pre-Test
Conference Goals and Overview
Faith H. Howarth, MSN, EdM, CRNP, CS
Neurodegeneration: The Clinical Evidence
Michael K. Racke, MD
Current Therapies and Clinical Trials
John Ratchford, MD
The Reading Room—Neuroimaging in the Clinical Setting
Nancy L. Sicotte, MD, FAAN
Increasing Patient Adherence to Optimize Neuroprotection
Kathleen Costello, MS, ANP-BC, MSCN
Educational Challenge: Managing Your Patient with MS
Moderated by John Ratchford, MD and Faith H. Howarth, MSN, EdM, CRNP, CS
Conclusion
Post-Test
Return to Top
Click on the green button below to listen to the podcast.
 To download the podcast, please right click on the image above and choose ' Save Target As'.
|
